首次使用靶向疗法两年后，甲氨蝶呤仍可用于治疗 RA：前瞻性 STRATEGE 2 研究的结果

{"title":"首次使用靶向疗法两年后，甲氨蝶呤仍可用于治疗 RA：前瞻性 STRATEGE 2 研究的结果","authors":"C. Gaujoux-Viala, E. Dernis, É. Senbel, H. Herman-Demars, J. Becker, A. Courbeyrette, R.M. Flipo","doi":"10.1016/j.rhum.2023.10.123","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21450,"journal":{"name":"Revue du Rhumatisme","volume":" 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Persistance du méthotrexate dans le traitement de la PR, deux ans après initiation d’une première thérapie ciblée : résultats de l’étude prospective STRATEGE 2\",\"authors\":\"C. Gaujoux-Viala, E. Dernis, É. Senbel, H. Herman-Demars, J. Becker, A. Courbeyrette, R.M. Flipo\",\"doi\":\"10.1016/j.rhum.2023.10.123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21450,\"journal\":{\"name\":\"Revue du Rhumatisme\",\"volume\":\" 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue du Rhumatisme\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.rhum.2023.10.123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue du Rhumatisme","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rhum.2023.10.123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}